Medical News

RSS
Higher negative emotional traits linked to fewer risks taken by bodies managed by directors

Higher negative emotional traits linked to fewer risks taken by bodies managed by directors

Medivir reports 24-week interim Phase 2b results of TMC435 in treatment-naïve patients with HCV genotype-1

Medivir reports 24-week interim Phase 2b results of TMC435 in treatment-naïve patients with HCV genotype-1

New website presenting latest in Alzheimer's disease research unveiled at AAICAD 2010

New website presenting latest in Alzheimer's disease research unveiled at AAICAD 2010

Irvine Scientific opens new Industrial Cell Culture media production facility in Tokyo, Japan

Irvine Scientific opens new Industrial Cell Culture media production facility in Tokyo, Japan

New approach of screening drugs that encourage stem cells to repair damaged tissue

New approach of screening drugs that encourage stem cells to repair damaged tissue

BCAN to celebrate first annual Bladder Cancer Awareness Day

BCAN to celebrate first annual Bladder Cancer Awareness Day

Counseling parents of infants about when to stop using bottle can reduce tooth decay, obesity and iron deficiency

Counseling parents of infants about when to stop using bottle can reduce tooth decay, obesity and iron deficiency

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Lectures on DermaVir to be presented at International Conference on Nanosciences & Nanotechnologies

Interim progress from Phase III TeloVac study of GV1001 vaccine announced

Interim progress from Phase III TeloVac study of GV1001 vaccine announced

Midatech, Immunotope form joint venture to develop antigen based products for immune therapies

Midatech, Immunotope form joint venture to develop antigen based products for immune therapies

Statement showing results of three-day meeting between Identa and U.S. representative issued

Statement showing results of three-day meeting between Identa and U.S. representative issued

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Addition of fat to mouse stem cells push them to develop into subcutaneous or visceral fat storage cells

Addition of fat to mouse stem cells push them to develop into subcutaneous or visceral fat storage cells

Reducing chronic pain, dry mouth could improve quality of life in head and neck cancer patients: Study

Reducing chronic pain, dry mouth could improve quality of life in head and neck cancer patients: Study

Drosophila fly study may aid in staving off diseases in humans using defensive bacteria

Drosophila fly study may aid in staving off diseases in humans using defensive bacteria

MDT releases statement questioning AGD's priorities

MDT releases statement questioning AGD's priorities

Vaccine manufacturers may be able to produce lower-cost HPV vaccines, say researchers

Vaccine manufacturers may be able to produce lower-cost HPV vaccines, say researchers

President Obama shoots a basket in 'Quest' to raise awareness about brain tumors

President Obama shoots a basket in 'Quest' to raise awareness about brain tumors

Educational psychologists use eye-tracking method for detecting lies

Educational psychologists use eye-tracking method for detecting lies

BRAIN AG acquires a minority share in Enzymicals AG

BRAIN AG acquires a minority share in Enzymicals AG

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.